Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | retinoic acid receptor, alpha | Starlite/ChEMBL | References |
Homo sapiens | retinoic acid receptor, gamma | Starlite/ChEMBL | References |
Homo sapiens | retinoic acid receptor, beta | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Brugia malayi | nuclear hormone receptor | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | Get druggable targets OG5_131607 | All targets in OG5_131607 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.1366 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0738 | 0.4171 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1016 | 0.6753 | 0.6753 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.1366 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0736 | 0.4161 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1166 | 0.8147 | 0.8147 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1016 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1086 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1086 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0458 | 0.1579 | 0.1579 |
Loa Loa (eye worm) | hypothetical protein | 0.0769 | 0.4465 | 0.4465 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.1366 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1086 | 0.7408 | 0.7408 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.1366 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1016 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1016 | 0.6753 | 0.6753 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | 0.0787 | 0.4625 | 0.4625 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1366 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0458 | 0.1579 | 0.1579 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.1366 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0738 | 0.4171 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1366 | 1 | 1 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.1366 | 1 | 1 |
Giardia lamblia | GTOR | 0.1366 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0736 | 0.4161 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0458 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0916 | 0.5829 | 0.5829 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0736 | 0.4161 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0808 | 0.4826 | 0.4826 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1086 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0738 | 0.4171 | 0.4171 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0806 | 0.4805 | 0.5 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.1366 | 1 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.1366 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0887 | 0.5555 | 0.5555 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0366 | 0.0729 | 0.0729 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.1366 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0816 | 0.4901 | 0.4901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0458 | 0.1579 | 0.1579 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.1088 | 0.7418 | 0.6934 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0567 | 0.2592 | 0.1204 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1366 | 1 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.1366 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0458 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0816 | 0.4901 | 0.4901 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.1016 | 0.6753 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.1366 | 1 | 1 |
Brugia malayi | nuclear hormone receptor | 0.0787 | 0.4625 | 0.3618 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.1366 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0816 | 0.4901 | 0.4901 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.1088 | 0.7418 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0808 | 0.4826 | 0.4826 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1016 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1016 | 0.6753 | 0.6753 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.1088 | 0.7418 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1086 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0458 | 0.1579 | 0.1579 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0646 | 0.3322 | 0.207 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1016 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0738 | 0.4171 | 0.4171 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 8 nM | Effective concentration for retinoic acid receptor RAR alpha transcriptional activation | ChEMBL. | 12372520 |
EC50 (functional) | = 8 nM | Effective concentration for retinoic acid receptor RAR alpha transcriptional activation | ChEMBL. | 12372520 |
EC50 (functional) | = 45 nM | Effective concentration for retinoic acid recptor RAR beta transcriptional activation | ChEMBL. | 12372520 |
EC50 (functional) | = 45 nM | Effective concentration for retinoic acid recptor RAR beta transcriptional activation | ChEMBL. | 12372520 |
EC50 (functional) | = 350 nM | Effective concentration for retinoic acid receptor RAR gamma transcriptional activation | ChEMBL. | 12372520 |
EC50 (functional) | = 350 nM | Effective concentration for retinoic acid receptor RAR gamma transcriptional activation | ChEMBL. | 12372520 |
Efficacy (functional) | = 69 % | Percent transcriptional activation of RAR alpha compared to 1 mM ATRA | ChEMBL. | 12372520 |
Efficacy (functional) | = 69 % | Percent transcriptional activation of RAR alpha compared to 1 mM ATRA | ChEMBL. | 12372520 |
Efficacy (functional) | = 78 % | Percent transcriptional activation of RAR beta compared to 1 mM ATRA | ChEMBL. | 12372520 |
Efficacy (functional) | = 78 % | Percent transcriptional activation of RAR beta compared to 1 mM ATRA | ChEMBL. | 12372520 |
Efficacy (functional) | = 85 % | Percent transcriptional activation of RAR gamma compared to 1 mM ATRA | ChEMBL. | 12372520 |
Efficacy (functional) | = 85 % | Percent transcriptional activation of RAR gamma compared to 1 mM ATRA | ChEMBL. | 12372520 |
Kd (binding) | = 2 nM | Binding affinity fo retinoic acid receptor RAR alpha | ChEMBL. | 12372520 |
Kd (binding) | = 2 nM | Binding affinity fo retinoic acid receptor RAR alpha | ChEMBL. | 12372520 |
Kd (binding) | = 380 nM | Binding affinity for retinoic acid receptor RAR beta | ChEMBL. | 12372520 |
Kd (binding) | = 380 nM | Binding affinity for retinoic acid receptor RAR beta | ChEMBL. | 12372520 |
Kd (binding) | = 990 nM | Binding affinity for retinoic acid receptor RAR gamma | ChEMBL. | 12372520 |
Kd (binding) | = 990 nM | Binding affinity for retinoic acid receptor RAR gamma | ChEMBL. | 12372520 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.